The volatility ratio for the week is 11.83%, and the volatility levels for the past 30 days are 4.87% for MDCX. The simple moving average for the past 20 days is -40.98% for MDCX’s stock, with a -40.87% simple moving average for the past 200 days.
Is It Worth Investing in Medicus Pharma Ltd (NASDAQ: MDCX) Right Now?
MDCX currently public float of 3.45M.The average trading volume of MDCX on November 18, 2024 was 15.35K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MDCX) stock’s latest price update
The stock of Medicus Pharma Ltd (NASDAQ: MDCX) has decreased by -15.47 when compared to last closing price of 2.65.Despite this, the company has seen a loss of -55.20% in its stock price over the last five trading days. proactiveinvestors.com reported 2024-11-16 that Medicus Pharma (TSX-V:MDCX, NASDAQ:MDCX) CEO and chairman Raza Bokhari joined Proactive to discuss the company’s recent listing on the Nasdaq, a key milestone for the biotechnology firm. Following their initial public offering (IPO) on the Nasdaq, Medicus Pharma (TSX-V:MDCX, NASDAQ:MDCX) raised $4 million to fund its ongoing Phase 2 proof-of-concept trial for a promising noninvasive treatment for basal cell carcinoma, the most common form of skin cancer.
MDCX Trading at -40.87% from the 50-Day Moving Average
After a stumble in the market that brought MDCX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.67% of loss for the given period.
Volatility was left at 4.87%, however, over the last 30 days, the volatility rate increased by 11.83%, as shares sank -36.72% for the moving average over the last 20 days.
During the last 5 trading sessions, MDCX fell by -55.20%, in comparison to the 20-day moving average, which settled at $3.80. In addition, Medicus Pharma Ltd saw -45.37% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MDCX
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.11.
Conclusion
In a nutshell, Medicus Pharma Ltd (MDCX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
